This study will compare the systemic and white adipose tissue inflammatory profile of individuals who are classified as lean and obese. Blood and white adipose tissue samples will be collected in the fasted state to assess inflammatory status. There is evidence to suggest that markers of inflammation in the blood and white adipose tissue increase with increasing levels of obesity. However, the white adipose tissue total protein content and phosphorylation of proteins involved in inflammatory pathways has not previously been compared between lean and obese individuals. The investigators hypothesise that obese individuals will have increased levels of inflammation in the blood and white adipose tissue, compared to their lean counterparts.
Study Type
OBSERVATIONAL
Enrollment
12
There is no intervention in this study
Loughborough University
Loughborough, United Kingdom
Protein expression (content and phosphorylation) of key markers of metabolic inflammation in white adipose tissue (for example assessment of Nuclear factor kappa B (NFKB) total protein and phosphorylation by western blot analysis)
This will be assessed following the collection of fasted white adipose tissue samples
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
Systemic Markers of Inflammation (for example C-reactive protein and interleukin 6 concentrations, determined by spectrophotometric assay/ ELISA)
This will be assessed following the collection of fasted white adipose tissue
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
Gene expression of key markers of metabolic inflammation in white adipose tissue
This will be assessed following the collection of fasted white adipose tissue
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
Characterisation of immune cell populations (monocyte subsets) from peripheral blood mononuclear cells (measured using flow cytometry analysis)
This will be assessed following the collection of fasted blood samples
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
Habitual Dietary Intake
This will be assessed following the collection of a 4 day weighed food diary
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
Physical Activity
Assessed using Actigraph accelerometers over a 4 day period
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
Fasting Serum Markers of Insulin Resistance (for example insulin and glucose concentrations, determined using an ELISA/ spectrophotometric assay)
This will be assessed following the collection of fasted blood samples
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
Fasting Serum Lipid Profile (for example total cholesterol, HDL cholesterol and triacylglycerol concentrations, measured using a spectrophotometric assay)
This will be assessed following the collection of fasted blood samples
Time frame: Cross-sectional (all outcome measures will be collected within a 2 week period)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.